Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01981356 · ClinicalTrials.gov registry record · Early Phase 1
Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis
A Early Phase 1 study of Psychotic Disorders, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT01981356: Completed Early Phase 1 study of Psychotic Disorders, sponsored by VA Office of Research and Development.
NCT01981356 is a Early Phase 1 study of Psychotic Disorders that has completed, run by VA Office of Research and Development. The registered enrollment target is 18 participants, below the 255-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01981356, a Early Phase 1 study of Psychotic Disorders, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
There is a substantial need for enhancing the efficacy and effectiveness of Veterans Health Administration (VHA) inpatient services for psychosis and tailoring them to support recovery. The proposed pilot study will explore whether Acceptance and Commitment Therapy (ACT), a recovery-oriented, evidence-based inpatient treatment, is a feasible, acceptable, safe, and effective adjunct for the inpatient treatment of Veterans with psychosis at a single VHA site. Additionally, an evaluation of barriers and facilitators to future implementation will be conducted. If promising, the data gained from the proposed study will support future evaluation, implementation and dissemination efforts that have the potential to improve inpatient treatment for psychosis and recovery, and thus, the lives of Veterans, while reducing costs for VHA.
Primary Outcome
Assesses changes in broad symptom domains (affect disturbance, positive symptoms, negative symptoms, resistance/hostility, activation) and specific symptoms (e.g., delusions). All scale items were averaged to obtain a total scale score. Scale scores are reported as percentage of total possible change, calculated as follow-up score minus baseline score divided by total points in scale. Minimum score is -100% change (a decrease of 100% of total possible score from baseline to follow-up assessment)
Conditions Studied
Interventions
- BEHAVIORAL Acceptance and Commitment Therapy
- OTHER Treatment as Usual (TAU)
Study Locations (1)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-04 |
| Phase | Early Phase 1 |
What the finished NCT01981356 record still lists
NCT01981356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 255-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Psychotic Disorders appearing as the primary indexed condition, and to 2 interventions - of which Acceptance and Commitment Therapy is the first listed.
NCT01981356 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01981356 about?
NCT01981356 is a clinical study titled "Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis". There is a substantial need for enhancing the efficacy and effectiveness of Veterans Health Administration (VHA) inpatient services for psychosis and tailoring them to support recovery. The proposed pilot study will explore whether Acceptance and Commitment Therapy (ACT), a recovery-oriented, eviden...
What is the current status of trial NCT01981356?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 18 participants. The study started on 2014-09. Estimated completion is 2015-04.
What conditions does trial NCT01981356 study?
This clinical trial studies the following conditions: Psychotic Disorders.
What interventions are being tested in trial NCT01981356?
The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL), Treatment as Usual (TAU) (OTHER).
Who is sponsoring clinical trial NCT01981356?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01981356 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychotic Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01981356's enrollment target sits among peer trials
18 21st of 22 higher than 2 of 22 other Psychotic Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Psychotic Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
-
A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences
RECRUITING · NA
-
Racial Disparities in the Expression of Paranoia
RECRUITING · NA
-
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
RECRUITING · NA
-
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
RECRUITING · NA
-
CBT-CP for Veterans With SMI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia